These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31618428)

  • 1. Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.
    Murrie B; Lappin J; Large M; Sara G
    Schizophr Bull; 2020 Apr; 46(3):505-516. PubMed ID: 31618428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    Am J Psychiatry; 2019 Sep; 176(9):711-719. PubMed ID: 31055966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cannabis and stimulant disorders on diagnostic stability in psychosis.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    J Clin Psychiatry; 2014 Apr; 75(4):349-56. PubMed ID: 24813404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition to Schizophrenia Spectrum Disorder Following Emergency Department Visits Due to Substance Use With and Without Psychosis.
    Myran DT; Harrison LD; Pugliese M; Solmi M; Anderson KK; Fiedorowicz JG; Perlman CM; Webber C; Finkelstein Y; Tanuseputro P
    JAMA Psychiatry; 2023 Nov; 80(11):1169-1174. PubMed ID: 37755727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia and violence: systematic review and meta-analysis.
    Fazel S; Gulati G; Linsell L; Geddes JR; Grann M
    PLoS Med; 2009 Aug; 6(8):e1000120. PubMed ID: 19668362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.
    Fusar-Poli P; Cappucciati M; Rutigliano G; Heslin M; Stahl D; Brittenden Z; Caverzasi E; McGuire P; Carpenter WT
    Schizophr Bull; 2016 Nov; 42(6):1395-1406. PubMed ID: 26980142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications.
    Aggarwal M; Banerjee A; Singh SM; Mattoo SK; Basu D
    Asian J Psychiatr; 2012 Sep; 5(3):220-4. PubMed ID: 22981049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.
    BELL DS
    Br J Psychiatry; 1965 Aug; 111():701-7. PubMed ID: 14337419
    [No Abstract]   [Full Text] [Related]  

  • 9. Substance-induced psychoses: a critical review of the literature.
    Fiorentini A; Volonteri LS; Dragogna F; Rovera C; Maffini M; Mauri MC; Altamura CA
    Curr Drug Abuse Rev; 2011 Dec; 4(4):228-40. PubMed ID: 21999698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases.
    Niemi-Pynttäri JA; Sund R; Putkonen H; Vorma H; Wahlbeck K; Pirkola SP
    J Clin Psychiatry; 2013 Jan; 74(1):e94-9. PubMed ID: 23419236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors.
    Myles N; Newall H; Nielssen O; Large M
    Curr Pharm Des; 2012; 18(32):5055-69. PubMed ID: 22716150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses.
    Kirkbride JB; Errazuriz A; Croudace TJ; Morgan C; Jackson D; Boydell J; Murray RM; Jones PB
    PLoS One; 2012; 7(3):e31660. PubMed ID: 22457710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study.
    Rosse RB; Collins JP; Fay-McCarthy M; Alim TN; Wyatt RJ; Deutsch SI
    Clin Neuropharmacol; 1994 Aug; 17(4):359-69. PubMed ID: 9316684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis.
    Starzer MSK; Nordentoft M; Hjorthøj C
    Am J Psychiatry; 2018 Apr; 175(4):343-350. PubMed ID: 29179576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study.
    Alderson HL; Semple DM; Blayney C; Queirazza F; Chekuri V; Lawrie SM
    Psychol Med; 2017 Oct; 47(14):2548-2555. PubMed ID: 28464965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years.
    Rössler W; Hengartner MP; Angst J; Ajdacic-Gross V
    Addiction; 2012 Jun; 107(6):1174-84. PubMed ID: 22151745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cannabis and psychosis--a review].
    Schaub M; Rössler W; Stohler R
    Praxis (Bern 1994); 2004 Jun; 93(23):997-1002. PubMed ID: 15233568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When does amphetamine-induced psychosis become schizophrenia?
    Flaum M; Schultz SK
    Am J Psychiatry; 1996 Jun; 153(6):812-5. PubMed ID: 8633695
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphetamine psychosis: a model for studying the onset and course of psychosis.
    Hermens DF; Lubman DI; Ward PB; Naismith SL; Hickie IB
    Med J Aust; 2009 Feb; 190(S4):S22-5. PubMed ID: 19220169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.